Developments with multi-target drugs for Alzheimer's disease: An overview of the current discovery approaches
JF González, AR Alcántara, AL Doadrio… - Expert opinion on …, 2019 - Taylor & Francis
Introduction: Alzheimer's disease (AD), the most common type of dementia among older
adults, is a chronic neurodegenerative pathology that causes a progressive loss of cognitive …
adults, is a chronic neurodegenerative pathology that causes a progressive loss of cognitive …
Multitarget directed ligand approaches for Alzheimer's disease: A Comprehensive Review
N Ramalakshmi, R RS, N CN - Mini Reviews in Medicinal …, 2021 - ingentaconnect.com
Background: Alzheimer's disease (AD) is a multifactorial neurodegenerative disease, and a
drug which targets a single protein would not provide a cure for this disease. Currently …
drug which targets a single protein would not provide a cure for this disease. Currently …
Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease
T Wang, X Liu, J Guan, S Ge, MB Wu, J Lin… - European Journal of …, 2019 - Elsevier
Complex diseases (eg, Alzheimer's disease) or infectious diseases are usually caused by
complicated and varied factors, including environmental and genetic factors. Multi-target …
complicated and varied factors, including environmental and genetic factors. Multi-target …
[HTML][HTML] Multi-targets: An unconventional drug development strategy for Alzheimer's disease
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that eventually leads
to dementia and death of the patient. Despite the enormous amounts of resources and …
to dementia and death of the patient. Despite the enormous amounts of resources and …
From combinations to multitarget‐directed ligands: A continuum in Alzheimer's disease polypharmacology
C Albertini, A Salerno… - Medicinal Research …, 2021 - Wiley Online Library
The continued drug discovery failures in complex neurodegenerative diseases, including
Alzheimer's disease (AD), has raised questions about the classical paradigm “one‐drug …
Alzheimer's disease (AD), has raised questions about the classical paradigm “one‐drug …
[HTML][HTML] Current pharmacotherapy and multi-target approaches for Alzheimer's disease
SL Cheong, JK Tiew, YH Fong, HW Leong, YM Chan… - Pharmaceuticals, 2022 - mdpi.com
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by decreased
synaptic transmission and cerebral atrophy with appearance of amyloid plaques and …
synaptic transmission and cerebral atrophy with appearance of amyloid plaques and …
Multi-target directed drugs as a modern approach for drug design towards Alzheimer's disease: an update
M de Freitas Silva, KST Dias, VS Gontijo… - Current Medicinal …, 2018 - ingentaconnect.com
Alzheimer's disease (AD) is a progressive multifactorial neurodegenerative disorder.
Currently, no effective treatment is available and this is due to multiple factors involved in …
Currently, no effective treatment is available and this is due to multiple factors involved in …
Recent advances in multi-target anti-Alzheimer disease compounds (2013 up to the present)
N Wang, P Qiu, W Cui, X Yan… - Current Medicinal …, 2019 - ingentaconnect.com
Since the last century, when scientists proposed the lock-and-key model, the discovery of
drugs has focused on the development of drugs acting on single target. However, single …
drugs has focused on the development of drugs acting on single target. However, single …
A perspective on multi-target drugs for Alzheimer's disease
O Benek, J Korabecny, O Soukup - Trends in pharmacological sciences, 2020 - cell.com
Alzheimer's disease (AD) has a complex pathophysiology that includes aggregation of
pathological proteins, impaired neurotransmission, increased oxidative stress, or microglia …
pathological proteins, impaired neurotransmission, increased oxidative stress, or microglia …
Multifaceted Alzheimer's disease: Building a roadmap for advancement of novel therapies
D Kaur, T Behl, A Sehgal, S Singh, N Sharma… - Neurochemical …, 2021 - Springer
Alzheimer's disease (AD) is one of the most prevailing neurodegenerative disorders of
elderly humans associated with cognitive damage. Biochemical, epigenetic, and …
elderly humans associated with cognitive damage. Biochemical, epigenetic, and …